Zydus and Synthon ink licensing and supply agreement for Ozanimod Capsules for US market
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The company has improved access to quality healthcare for seniors across both urban and rural areas
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The accelerated approval is supported by results from part 1 of the ESSENCE trial
Subscribe To Our Newsletter & Stay Updated